Table 2 Univariate and multivariate analyses of the factors associated with IFN-γ production in response to the PPD antigen

 ≥ 200 cells/mm³

1

1

 < 200 cells/mm³

1.375 (0.332;5.694)

0.661

5.547 (1.348;22.821)

0.018

 Male

1

 Female

0.242 (0.052; 1.118)

0.069

 38–44

1

1

 32–18

3.87 (1.336;11.212)

0.013

2.808 (1.13;6.98)

0.026

 37–32

1.256 (0.305;5.169)

0.752

1.061 (0.292; 3.862)

0.928

 Pulmonary

1

1

 Disseminated

1.173 (0.285; 4.836)

0.825

1.531 (0.468; 5.01)

0.482

 Extrapulmonary

4.275 (1.122; 16.285)

0.033

6.431 (1.566; 26.408)

0.010

 White

1

 Black

2.544 (0.603; 10.737)

0.204

 Mulattoes

1.376 (0.283; 6.705)

0.692

 600 mg

1

1

 800 mg

3.187 (0.901;11.266)

0.072

3.505 (1.04;11.817)

0.043

 Detectable

1

 Undetectable

2.348 (1.228;4.489)

0.010

 Follow-up CD4 cells/mm³

 ≥200 cells/mm³

1.003 (1.001; 1.005)

0.002

1.006 (1.003; 1.009)

<0.001

 <200 cells/mm³

1.004 (0.996; 1.1014)

0.312

1.011 (1.002; 1.02)

0.016

Follow-up %HLA-DR⁺/CD3⁺ T cells

0.994 (0.975; 1.014)

0.559

Follow-up % CD8⁺/38⁺ T cells

0.998 (0.972; 1.024)

0.851

Follow-up IFN-γ plasmatic

0.989 (0.946; 1.033)

0.61